49.93
price down icon2.00%   -1.02
after-market After Hours: 49.93
loading

Mirum Pharmaceuticals Inc Stock (MIRM) Latest News

pulisher
05:27 AM

Mirum Pharmaceuticals' SWOT analysis: FDA approvals boost rare disease stock - Investing.com

05:27 AM
pulisher
Feb 24, 2025

Deal pays off for drugmaker with approval for rare cholesterol-related disease treatment - The Business Journals

Feb 24, 2025
pulisher
Feb 24, 2025

Mirum Pharmaceuticals Says US FDA Approves Cerebrotendinous Xanthomatosis' Treatment Drug - Marketscreener.com

Feb 24, 2025
pulisher
Feb 24, 2025

Mirum’s CTEXLI™ (chenodiol) Tablets Receives FDA Approval for Treatment of Cerebrotendinous Xanthomatosis (CTX) - The Bakersfield Californian

Feb 24, 2025
pulisher
Feb 24, 2025

Medical Milestone: First Treatment for CTX Patients Shows 20x Better Results Than Placebo - StockTitan

Feb 24, 2025
pulisher
Feb 24, 2025

JMP maintains $74 target on Mirum Pharmaceuticals stock - Investing.com India

Feb 24, 2025
pulisher
Feb 21, 2025

Mirum’s Ctexli wins FDA nod in cerebrotendinous xanthomatosis - BioWorld Online

Feb 21, 2025
pulisher
Feb 21, 2025

US FDA approves Mirum Pharma's genetic disorder drug - Reuters

Feb 21, 2025
pulisher
Feb 21, 2025

Mirum Pharmaceuticals' Lipid Storage Disease Treatment Gets FDA Approval -February 21, 2025 at 01:48 pm EST - Marketscreener.com

Feb 21, 2025
pulisher
Feb 21, 2025

US FDA approves Mirum Pharma’s genetic disorder drug - KFGO

Feb 21, 2025
pulisher
Feb 21, 2025

FDA Approves Mirum Pharmaceuticals Treatment for Lipid-Storage Disease -February 21, 2025 at 01:20 pm EST - Marketscreener.com

Feb 21, 2025
pulisher
Feb 21, 2025

FDA Approves Mirum Pharmaceuticals' Drug As First For Genetic Disorder With Inability To Break-Down Cholesterol - Benzinga

Feb 21, 2025
pulisher
Feb 21, 2025

Mirum gains FDA approval of chenodiol for rare lipid storage disease - Seeking Alpha

Feb 21, 2025
pulisher
Feb 21, 2025

FDA Approves Mirum Pharmaceuticals Treatment for Lipid-Storage Disease - MarketWatch

Feb 21, 2025
pulisher
Feb 21, 2025

US FDA approves Mirum Pharma's genetic disorder drug -February 21, 2025 at 12:07 pm EST - Marketscreener.com

Feb 21, 2025
pulisher
Feb 21, 2025

US FDA approves Mirum Pharma's genetic disorder drug -February 21, 2025 at 11:54 am EST - Marketscreener.com

Feb 21, 2025
pulisher
Feb 19, 2025

Mirum Pharmaceuticals to Announce Fourth Quarter and Year-End 2024 Financial Results and Host Conference Call on February 26, 2025 - BioSpace

Feb 19, 2025
pulisher
Feb 19, 2025

Mirum Pharmaceuticals to Announce Fourth Quarter and Year-End 20 - WICZ

Feb 19, 2025
pulisher
Feb 19, 2025

Mirum Pharma's Critical Q4 Earnings Call: Will 2024 Results Signal Growth Momentum? - StockTitan

Feb 19, 2025
pulisher
Feb 19, 2025

High Growth Tech Stocks in United States to Watch - Simply Wall St

Feb 19, 2025
pulisher
Feb 19, 2025

Mirum Pharmaceuticals stock soars to all-time high of $53.52 - Investing.com India

Feb 19, 2025
pulisher
Feb 19, 2025

Mirum Pharmaceuticals stock soars to all-time high of $53.52 By Investing.com - Investing.com Nigeria

Feb 19, 2025
pulisher
Feb 18, 2025

Mirum Pharmaceuticals (MIRM) is on the Move, Here's Why the Trend Could be Sustainable - MSN

Feb 18, 2025
pulisher
Feb 18, 2025

How to Take Advantage of moves in (MIRM) - news.stocktradersdaily.com

Feb 18, 2025
pulisher
Feb 16, 2025

Mirum Pharmaceuticals stock soars to all-time high of $48.94 - MSN

Feb 16, 2025
pulisher
Feb 11, 2025

Alagille Syndrome Market Expected to rise, 2034 | Mirum Pharmaceuticals, Albireo, expected to drive market - Barchart

Feb 11, 2025
pulisher
Feb 10, 2025

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance

Feb 10, 2025
pulisher
Feb 10, 2025

Mirum Pharma (MIRM) Unveils Strategic Talent Package: 74K Shares in Equity Grants - StockTitan

Feb 10, 2025
pulisher
Feb 09, 2025

SG Americas Securities LLC Sells 13,575 Shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) - MarketBeat

Feb 09, 2025
pulisher
Feb 09, 2025

Insider Selling: Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) SVP Sells 1,064 Shares of Stock - MarketBeat

Feb 09, 2025
pulisher
Feb 08, 2025

Mirum Pharmaceuticals (NASDAQ:MIRM) Hits New 52-Week HighHere's What Happened - MarketBeat

Feb 08, 2025
pulisher
Feb 08, 2025

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) COO Sells $126,673.94 in Stock - MarketBeat

Feb 08, 2025
pulisher
Feb 08, 2025

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) CEO Christopher Peetz Sells 9,102 Shares - MarketBeat

Feb 08, 2025
pulisher
Feb 07, 2025

(MIRM) Technical Pivots with Risk Controls - Stock Traders Daily

Feb 07, 2025
pulisher
Feb 07, 2025

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Receives Average Rating of "Buy" from Brokerages - MarketBeat

Feb 07, 2025
pulisher
Feb 06, 2025

Golden State Equity Partners Has $801,000 Stock Position in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) - MarketBeat

Feb 06, 2025
pulisher
Feb 06, 2025

Genomenon and Mirum Pharmaceuticals Join Forces to Enhance CTX Disease Awareness and Diagnosis - PR Web

Feb 06, 2025
pulisher
Feb 06, 2025

Alagille Syndrome Market is set for steady growth, with a robust - openPR

Feb 06, 2025
pulisher
Feb 05, 2025

Mirum Pharmaceuticals president sells $126,680 in stock - MSN

Feb 05, 2025
pulisher
Feb 05, 2025

Mirum Pharmaceuticals (NASDAQ:MIRM) shareholder returns have been solid, earning 192% in 5 years - Simply Wall St

Feb 05, 2025
pulisher
Feb 04, 2025

Major Insider Stock Sales at Mirum Pharmaceuticals! - TipRanks

Feb 04, 2025
pulisher
Feb 04, 2025

Mirum Pharmaceuticals president sells $126,680 in stock By Investing.com - Investing.com Canada

Feb 04, 2025
pulisher
Feb 01, 2025

Mirum Pharmaceuticals (NASDAQ:MIRM) Reaches New 1-Year HighShould You Buy? - MarketBeat

Feb 01, 2025
pulisher
Jan 31, 2025

Mirum Pharmaceuticals stock soars to all-time high of $49.59 - MSN

Jan 31, 2025
pulisher
Jan 31, 2025

First Week of MIRM March 21st Options Trading - Nasdaq

Jan 31, 2025
pulisher
Jan 31, 2025

Mirum Pharmaceuticals stock soars to all-time high of $49.59 By Investing.com - Investing.com UK

Jan 31, 2025
pulisher
Jan 30, 2025

Recent Price Trend in Mirum Pharmaceuticals (MIRM) is Your Friend, Here's Why - Yahoo Finance

Jan 30, 2025
$74.40
price up icon 0.53%
$22.96
price up icon 2.04%
$33.69
price down icon 0.33%
$357.50
price down icon 0.20%
$110.97
price down icon 5.14%
biotechnology ONC
$259.70
price up icon 0.47%
Cap:     |  Volume (24h):